PrismML is back in the news today after the AI startup’s CEO told CNBC that Apple is looking at the company’s technology. The company has also released its Bonsai 27B model that it says runs on iPhone ...

I don't need to tell you that Stardew Valley is not a 3D game, and if I do, your understanding of dimensions is unsettling to ...

Discover how heterogeneous compute templates optimize fast token generation and lower total cost of ownership for enterprise ...

In this post, we will show you how to create email templates in the new Outlook app for Windows 11. Creating email or message templates in Microsoft Outlook (classic) involved manually composing an ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

In one of the most memorable interviews of my career thus far, I was at my desk, head in my hands, talking on the phone to a physicist about extra dimensions. I was trying to understand what it means ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

We all know we live in three-dimensional space. But what does it mean when people talk about four dimensions? Is it just a bigger kind of space? Is it "space-time," the popular idea which emerged from ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...